Walgreens Boots Alliance has announced a significant restructuring plan, revealing its intention to close 1,200 retail locations over the next three years. This decision comes as the company grapples with ongoing financial difficulties, reporting an operating loss of $978 million from June to August 2024, a stark increase from the $450 million loss during the same period last year as detailed in a report by CNBC.
The closures will affect approximately 14 per cent of Walgreens’ total outlets in the United States, which currently number over 8,000. In the upcoming fiscal year 2025, around 500 of these stores are expected to shut down.
During a recent earnings call, CEO Tim Wentworth stated that while closing locations is never an easy decision, it is necessary for the long-term health of the company. “We must enhance our ability to react to a shifting environment,” he noted.
The strategic closures are part of a broader effort to create a “healthier store base.” Wentworth emphasised that most employees affected by the closures will be redeployed to other locations. The company plans to focus investments on its remaining stores, aiming to adapt more effectively to evolving consumer habits and purchasing trends.
Walgreens has faced mounting pressure in recent years as it attempts to transition into a healthcare destination amid fierce competition from rivals such as CVS Health and Amazon. The company has already implemented extensive cost-cutting measures, exceeding its target of reducing $1 billion in expenses during the last fiscal year.
However, analysts caution that these store closures may only be the initial steps in what could be a lengthy and challenging recovery process.
In addition to the store closures, Walgreens has been reevaluating its investments in VillageMD, a primary care provider it had previously invested billions in. Earlier this year, the company disclosed an impairment charge related to VillageMD and announced plans to close 160 clinics.
This shift indicates a potential strategic pivot as Walgreens seeks to refocus on its core competencies as a retail pharmacy-led organisation.
Despite these challenges, Walgreens’ stock experienced a notable surge of 12.8 per cent following the earnings report—its largest single-day increase since 2008. The positive market reaction suggests that investors are cautiously optimistic about the company’s new strategies aimed at revitalising its financial performance.
As Walgreens navigates these turbulent waters, it remains committed to enhancing its service offerings while streamlining operations. The coming months will be critical as the company works to implement these changes and adapt to an increasingly competitive landscape in the retail pharmacy sector.